Skye Bioscience growth metrics data for the quarter ended Jun 2026. These growth metrics cover 51 quarters of results from Apr 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Apr2013 | Jul2013 | Oct2013 | Apr2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) | -10.55% | -74.40% | -54.44% | -62.84% | -48.57% | -1,412.66% | -1,061.41% | 2.72% | -558.22% | 94.93% | 91.64% | -22.47% | 39.88% | -2,293.22% | -57,418.61% | 28.83% | |||||||||||||||||||||||||||||||||||
| Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y) | 18.72% | -3.59% | -37.55% | -40.53% | -208.54% | -133.18% | -28.95% | -121.11% | -10.20% | -14.44% | -24.72% | -80.48% | -163.83% | -723.35% | -224.60% | -503.56% | |||||||||||||||||||||||||||||||||||
| Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y) | -38.40% | 16.25% | -1.53% | -25.40% | -61.49% | -104.38% | -260.55% | -261.04% | -222.39% | ||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage Ratio (QoQ)Interest Cover (QoQ) | 3.27% | -32.96% | -17.20% | -8.04% | 11.75% | -1,253.64% | 10.01% | 90.95% | -497.14% | 89.57% | -48.22% | -32.64% | -193.11% | -315.31% | -3,462.22% | 41.83% | |||||||||||||||||||||||||||||||||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -0.01M | 0.01M | 0.00M | -0.00M | -0.02M | -0.02M | -0.02M | -0.04M | -0.02M | 0.01M | 0.02M | 0.06M | 0.05M | 0.02M | 0.00M | -0.00M | -0.01M | -0.01M | -0.02M | -0.03M | |||||||||||||||||||||||||||||||
| Return on Assets [ROA] Growth (3y)ROA Growth (3y) | 0.08M | 0.12M | 0.03M | -0.03M | -0.04M | -0.11M | -0.13M | 0.02M | -0.05M | -0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.01M | 0.01M | 0.02M | 0.02M | 0.01M | 0.03M | |||||||||||||||||||||||||||||||
| Return on Assets [ROA] Growth (5y)ROA Growth (5y) | 0.02M | 0.05M | 0.05M | 0.06M | 0.06M | 0.04M | 0.02M | -0.02M | 0.04M | 0.10M | 0.03M | -0.02M | -0.02M | -0.08M | -0.11M | 0.08M | -0.01M | 0.00M | -0.01M | -0.02M | |||||||||||||||||||||||||||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | 0.00M | 835.00 | -0.00M | -0.01M | -0.01M | -0.00M | 978.00 | -0.03M | 0.01M | 0.02M | 0.02M | 0.00M | 0.00M | -927.00 | -0.00M | -0.00M | -0.00M | -0.01M | -0.01M | -0.01M | |||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | 0.05M | 0.01M | 0.00M | -0.11M | 0.00M | -0.00M | -0.01M | -0.02M | -0.04M | -0.13M | |||||||||||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y) | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.11M | |||||||||||||||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y) | 1.03M | 0.07M | 0.05M | 0.00M | -0.02M | -0.12M | |||||||||||||||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | 0.01M | -0.00M | -0.01M | -0.10M | 0.00M | 0.00M | -0.00M | -0.00M | -0.00M | -0.00M | -0.01M | -0.02M | -0.10M | ||||||||||||||||||||||||||||||||||||||
| Return on Equity [ROE] Growth (1y)ROE Growth (1y) | 0.05M | 0.02M | -0.05M | 0.00M | -0.00M | -0.01M | -0.02M | -0.03M | -0.11M | ||||||||||||||||||||||||||||||||||||||||||
| Return on Equity [ROE] Growth (3y)ROE Growth (3y) | 0.03M | 0.02M | 0.01M | 0.01M | 0.02M | 0.07M | |||||||||||||||||||||||||||||||||||||||||||||
| Return on Equity [ROE] Growth (5y)ROE Growth (5y) | 0.04M | 0.00M | -0.09M | ||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Equity [ROE] (QoQ)ROE (QoQ) | 0.02M | 0.00M | -0.01M | -0.06M | 0.00M | 0.00M | -833.00 | -0.00M | -0.00M | -0.01M | -0.01M | -0.02M | -0.08M | ||||||||||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y) | 0.03M | -0.01M | -0.88M | 0.08M | |||||||||||||||||||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC] Growth (3y)ROIC Growth (3y) | -0.04M | 0.02M | 0.01M | 0.01M | |||||||||||||||||||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC] Growth (5y)ROIC Growth (5y) | -0.09M | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ) | 0.01M | 0.00M | -0.86M | 0.08M | 0.00M | 0.00M | -0.00M | -0.08M |
Pull Skye Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=SKYE&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "SKYE", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=SKYE&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();